Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX7WNC
|
||||
| Drug Name |
2-(3-methoxybenzyloxy)-5-(6-methoxy-7-(2-methoxyethoxy)quinazolin-4-ylamino)cyclohexa-2,5-diene-1,4-dione
|
||||
| Synonyms |
CHEMBL242349
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H25N3O7
|
||||
| Canonical SMILES |
COCCOc1cc2ncnc(NC3=CC(=O)C(=CC3=O)OCc4cccc(OC)c4)c2cc1OC
|
||||
| InChI |
InChI=1S/C26H25N3O7/c1-32-7-8-35-25-12-19-18(10-24(25)34-3)26(28-15-27-19)29-20-11-22(31)23(13-21(20)30)36-14-16-5-4-6-17(9-16)33-2/h4-6,9-13,15H,7-8,14H2,1-3H3,(H,27,28,29)
|
||||
| InChIKey |
ASOPRZPYNIPJKT-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
| Epidermal growth factor receptor III | Target Info | [1587926] | |||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| VEGF signaling pathway | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| Beta3 integrin cell surface interactions | |||||
| Signaling events mediated by TCPTP | |||||
| SHP2 signaling | |||||
| S1P1 pathway | |||||
| VEGF and VEGFR signaling network | |||||
| Integrins in angiogenesis | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| Notch-mediated HES/HEY network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.